ACTRN12609001026213招募中未知
Randomized, double-blind, placebo-controlled trial investigating the effect of iodine supplementation on cognition in school-aged children
niversity of Adelaide0 个研究点目标入组 350 人开始时间: 2009年11月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 8 Years 至 12 Years（—）
- 性别
- All
入选标准
- •Mildly iodine-deficient (i.e., a median urinary iodine concentration level of 50-99 micrograms per litre in the study population)
- •No history of thyroid disease
- •Not taking iodine-containing supplements
排除标准
- •History of thyroid disease;
- •Taking iodine-containing supplements
研究者
相似试验
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled trial to determine the capacity of VAK694 to elicit long term immune tolerance when combined with subcutaneous allergen immunotherapy for the treatment of seasonal allergic rhinitisEUCTR2009-013429-40-GBovartis Pharma Services AG
进行中（未招募）
1 期
Study of RV521 for the treatment of adults who have received a blood cell transplant and that have a respiratory infection caused by the virus RSVEUCTR2019-003746-33-FRReViral Ltd.200
招募中
3 期
Efficacy of Aripiprazole adjunctive treatment on body weight, metabolic parameters, clinical efficacy, and adverse events in people with psychotic disorders on treatment with Clozapine â?? A randomized, double-blind, placebo-controlled trialSchizoaffective disorderAntipsychotic induced weight gainMetabolic syndromeCTRI/2013/02/003397Christian Medical College60
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled trial to compare the effect, three months of follow-on pulse pressure and vascular function of isosorbide mononitrate extended release, associated with antihypertensive treatment in patients over 65 years refractory isolated systolic hypertension.Refractory isolated systolic hypertensionEUCTR2012-002988-10-ESFundación para la investigacion Biomedica
进行中（未招募）
1 期
Efficacy and safety of intravenous neridronic acid in CRPSEUCTR2016-003833-91-ESGrünenthal GmbH360